Literature DB >> 16670495

Pyogenic granuloma formation following placement of the Medennium SmartPLUG punctum plug.

Timothy Y Chou1, Henry D Perry, Eric D Donnenfeld, Renee Solomon.   

Abstract

PURPOSE: To report a complication, not previously described, of the Medennium SmartPLUG, which is a new punctal plug with a novel design.
METHODS: Two case reports are detailed, including clinical and pathologic photographs.
RESULTS: Case 1 is a 58-year-old woman with Sjögren syndrome. Nearly 2 years following placement of a SmartPLUG in her right lower canaliculus, the patient presented with an erythematous, papillomatous growth overlying her punctum. Biopsy demonstrated pyogenic granuloma. Case 2 is a 62-year-old woman with dry eye. Exactly 2 years after a SmartPLUG was place in her right lower canaliculus, she also developed a pyogenic granuloma. After irrigation to remove the plug, the growth decreased in size.
CONCLUSION: Pyogenic granuloma can develop as a late complication of the Medennium SmartPLUG punctum plug.

Entities:  

Mesh:

Year:  2006        PMID: 16670495     DOI: 10.1097/01.ico.0000183489.78012.7a

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  3 in total

1.  Corneal sensitivity, ocular surface health and tear film stability after punctal plug therapy of aqueous deficient dry eye.

Authors:  Azza Mohamed Ahmed Said; Mona Elsayed Farag; Tarek Mohamed Abdulla; Othman Ali Othman Ziko; Wesam Mohamed Osman
Journal:  Int J Ophthalmol       Date:  2016-11-18       Impact factor: 1.779

2.  Clinical efficacy of the SmartPlug™ in the treatment of primary Sjogren's syndrome with keratoconjunctivitis sicca: one-year follow-up study.

Authors:  Sait Egrilmez; Fatih Aslan; Gonca Karabulut; Yasemin Kabasakal; Ayse Yagci
Journal:  Rheumatol Int       Date:  2010-05-21       Impact factor: 2.631

Review 3.  Comprehensive Review of the Literature on Existing Punctal Plugs for the Management of Dry Eye Disease.

Authors:  Naz Jehangir; Greg Bever; S M Jafar Mahmood; Majid Moshirfar
Journal:  J Ophthalmol       Date:  2016-03-07       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.